NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)

Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) explained in plain language.

Never miss a new study

Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) trials appear

Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New eye drops aim to boost blood flow for vision conditions

Disease control Recruiting now

This is a small, early-stage study testing whether a new eye drop called QLS-111 can improve blood flow and widen blood vessels in the back of the eye. It will involve 14 people with non-proliferative diabetic retinopathy, open-angle glaucoma, or normal tension glaucoma. Particip…

Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)

Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)

Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) trials appear

New eye drops aim to boost blood flow for vision conditions